nodes	percent_of_prediction	percent_of_DWPC	metapath
Podofilox—Etoposide—peripheral nervous system neoplasm	0.47	1	CrCtD
Podofilox—Teniposide—Etoposide—peripheral nervous system neoplasm	0.267	1	CrCrCtD
Podofilox—TUBA4A—Vincristine—peripheral nervous system neoplasm	0.106	0.488	CbGbCtD
Podofilox—TUBB—Vincristine—peripheral nervous system neoplasm	0.0403	0.186	CbGbCtD
Podofilox—TOP2A—Epirubicin—peripheral nervous system neoplasm	0.0252	0.117	CbGbCtD
Podofilox—TOP2A—Etoposide—peripheral nervous system neoplasm	0.0196	0.0909	CbGbCtD
Podofilox—TOP2A—Doxorubicin—peripheral nervous system neoplasm	0.0134	0.062	CbGbCtD
Podofilox—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.00402	0.0186	CbGbCtD
Podofilox—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.00374	0.0173	CbGbCtD
Podofilox—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00172	0.00795	CbGbCtD
Podofilox—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00157	0.00728	CbGbCtD
Podofilox—Skin burning sensation—Tretinoin—peripheral nervous system neoplasm	0.00134	0.0298	CcSEcCtD
Podofilox—Skin burning sensation—Isotretinoin—peripheral nervous system neoplasm	0.00134	0.0298	CcSEcCtD
Podofilox—Localized exfoliation—Tretinoin—peripheral nervous system neoplasm	0.00121	0.027	CcSEcCtD
Podofilox—Localized exfoliation—Isotretinoin—peripheral nervous system neoplasm	0.00121	0.027	CcSEcCtD
Podofilox—Excoriation—Tretinoin—peripheral nervous system neoplasm	0.00108	0.0241	CcSEcCtD
Podofilox—Excoriation—Isotretinoin—peripheral nervous system neoplasm	0.00108	0.0241	CcSEcCtD
Podofilox—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00107	0.00497	CbGbCtD
Podofilox—Scab—Isotretinoin—peripheral nervous system neoplasm	0.00103	0.0229	CcSEcCtD
Podofilox—Scab—Tretinoin—peripheral nervous system neoplasm	0.00103	0.0229	CcSEcCtD
Podofilox—Skin burning sensation—Alitretinoin—peripheral nervous system neoplasm	0.00101	0.0226	CcSEcCtD
Podofilox—Localized exfoliation—Alitretinoin—peripheral nervous system neoplasm	0.000917	0.0205	CcSEcCtD
Podofilox—Excoriation—Alitretinoin—peripheral nervous system neoplasm	0.000818	0.0183	CcSEcCtD
Podofilox—Scab—Alitretinoin—peripheral nervous system neoplasm	0.000777	0.0173	CcSEcCtD
Podofilox—Application site pain—Tretinoin—peripheral nervous system neoplasm	0.000741	0.0165	CcSEcCtD
Podofilox—Application site pain—Isotretinoin—peripheral nervous system neoplasm	0.000741	0.0165	CcSEcCtD
Podofilox—Application site pain—Alitretinoin—peripheral nervous system neoplasm	0.000562	0.0125	CcSEcCtD
Podofilox—Redness—Isotretinoin—peripheral nervous system neoplasm	0.000483	0.0108	CcSEcCtD
Podofilox—Redness—Tretinoin—peripheral nervous system neoplasm	0.000483	0.0108	CcSEcCtD
Podofilox—Blister—Isotretinoin—peripheral nervous system neoplasm	0.000452	0.0101	CcSEcCtD
Podofilox—Blister—Tretinoin—peripheral nervous system neoplasm	0.000452	0.0101	CcSEcCtD
Podofilox—Skin ulcer—Isotretinoin—peripheral nervous system neoplasm	0.000419	0.00935	CcSEcCtD
Podofilox—Skin ulcer—Tretinoin—peripheral nervous system neoplasm	0.000419	0.00935	CcSEcCtD
Podofilox—Skin ulcer—Melphalan—peripheral nervous system neoplasm	0.000413	0.00923	CcSEcCtD
Podofilox—Tingling sensation—Isotretinoin—peripheral nervous system neoplasm	0.000406	0.00905	CcSEcCtD
Podofilox—Tingling sensation—Tretinoin—peripheral nervous system neoplasm	0.000406	0.00905	CcSEcCtD
Podofilox—Stinging—Isotretinoin—peripheral nervous system neoplasm	0.000402	0.00898	CcSEcCtD
Podofilox—Stinging—Tretinoin—peripheral nervous system neoplasm	0.000402	0.00898	CcSEcCtD
Podofilox—Tingling sensation—Melphalan—peripheral nervous system neoplasm	0.0004	0.00894	CcSEcCtD
Podofilox—Tenderness—Isotretinoin—peripheral nervous system neoplasm	0.000374	0.00834	CcSEcCtD
Podofilox—Tenderness—Tretinoin—peripheral nervous system neoplasm	0.000374	0.00834	CcSEcCtD
Podofilox—Redness—Alitretinoin—peripheral nervous system neoplasm	0.000366	0.00817	CcSEcCtD
Podofilox—Skin discolouration—Isotretinoin—peripheral nervous system neoplasm	0.000361	0.00806	CcSEcCtD
Podofilox—Skin discolouration—Tretinoin—peripheral nervous system neoplasm	0.000361	0.00806	CcSEcCtD
Podofilox—Ulcer—Isotretinoin—peripheral nervous system neoplasm	0.000345	0.00769	CcSEcCtD
Podofilox—Ulcer—Tretinoin—peripheral nervous system neoplasm	0.000345	0.00769	CcSEcCtD
Podofilox—Blister—Alitretinoin—peripheral nervous system neoplasm	0.000343	0.00765	CcSEcCtD
Podofilox—Ulcer—Melphalan—peripheral nervous system neoplasm	0.00034	0.00759	CcSEcCtD
Podofilox—Inflammation—Tretinoin—peripheral nervous system neoplasm	0.000336	0.0075	CcSEcCtD
Podofilox—Inflammation—Isotretinoin—peripheral nervous system neoplasm	0.000336	0.0075	CcSEcCtD
Podofilox—TOP2A—Irinotecan—Topotecan—peripheral nervous system neoplasm	0.000328	0.268	CbGdCrCtD
Podofilox—Skin ulcer—Alitretinoin—peripheral nervous system neoplasm	0.000317	0.00708	CcSEcCtD
Podofilox—Skin exfoliation—Isotretinoin—peripheral nervous system neoplasm	0.000311	0.00695	CcSEcCtD
Podofilox—Skin exfoliation—Tretinoin—peripheral nervous system neoplasm	0.000311	0.00695	CcSEcCtD
Podofilox—Tingling sensation—Alitretinoin—peripheral nervous system neoplasm	0.000307	0.00686	CcSEcCtD
Podofilox—Skin exfoliation—Melphalan—peripheral nervous system neoplasm	0.000307	0.00686	CcSEcCtD
Podofilox—Stinging—Alitretinoin—peripheral nervous system neoplasm	0.000305	0.00681	CcSEcCtD
Podofilox—Tenderness—Alitretinoin—peripheral nervous system neoplasm	0.000283	0.00632	CcSEcCtD
Podofilox—Ulcer—Dactinomycin—peripheral nervous system neoplasm	0.000282	0.00629	CcSEcCtD
Podofilox—Skin discolouration—Alitretinoin—peripheral nervous system neoplasm	0.000274	0.00611	CcSEcCtD
Podofilox—Swelling—Isotretinoin—peripheral nervous system neoplasm	0.000268	0.00599	CcSEcCtD
Podofilox—Swelling—Tretinoin—peripheral nervous system neoplasm	0.000268	0.00599	CcSEcCtD
Podofilox—Ulcer—Alitretinoin—peripheral nervous system neoplasm	0.000261	0.00583	CcSEcCtD
Podofilox—Inflammation—Alitretinoin—peripheral nervous system neoplasm	0.000255	0.00569	CcSEcCtD
Podofilox—Dermatitis bullous—Topotecan—peripheral nervous system neoplasm	0.00025	0.00557	CcSEcCtD
Podofilox—Dermatitis bullous—Isotretinoin—peripheral nervous system neoplasm	0.000248	0.00553	CcSEcCtD
Podofilox—Dermatitis bullous—Tretinoin—peripheral nervous system neoplasm	0.000248	0.00553	CcSEcCtD
Podofilox—Tenderness—Cisplatin—peripheral nervous system neoplasm	0.000241	0.00539	CcSEcCtD
Podofilox—Tingling sensation—Etoposide—peripheral nervous system neoplasm	0.00024	0.00536	CcSEcCtD
Podofilox—Skin exfoliation—Alitretinoin—peripheral nervous system neoplasm	0.000236	0.00526	CcSEcCtD
Podofilox—Ulcer—Cisplatin—peripheral nervous system neoplasm	0.000223	0.00497	CcSEcCtD
Podofilox—Dry skin—Tretinoin—peripheral nervous system neoplasm	0.000217	0.00484	CcSEcCtD
Podofilox—Dry skin—Isotretinoin—peripheral nervous system neoplasm	0.000217	0.00484	CcSEcCtD
Podofilox—Skin discolouration—Etoposide—peripheral nervous system neoplasm	0.000214	0.00477	CcSEcCtD
Podofilox—Ulcer—Etoposide—peripheral nervous system neoplasm	0.000204	0.00455	CcSEcCtD
Podofilox—Swelling—Alitretinoin—peripheral nervous system neoplasm	0.000203	0.00454	CcSEcCtD
Podofilox—Skin exfoliation—Cisplatin—peripheral nervous system neoplasm	0.000201	0.00449	CcSEcCtD
Podofilox—Inflammation—Etoposide—peripheral nervous system neoplasm	0.000199	0.00444	CcSEcCtD
Podofilox—TOP2A—Vindesine—Vincristine—peripheral nervous system neoplasm	0.000195	0.159	CbGdCrCtD
Podofilox—Dermatitis bullous—Alitretinoin—peripheral nervous system neoplasm	0.000188	0.00419	CcSEcCtD
Podofilox—Skin exfoliation—Etoposide—peripheral nervous system neoplasm	0.000184	0.00411	CcSEcCtD
Podofilox—Haematuria—Tretinoin—peripheral nervous system neoplasm	0.000174	0.00388	CcSEcCtD
Podofilox—Haematuria—Isotretinoin—peripheral nervous system neoplasm	0.000174	0.00388	CcSEcCtD
Podofilox—Haemoglobin—Topotecan—peripheral nervous system neoplasm	0.000166	0.0037	CcSEcCtD
Podofilox—Haemorrhage—Topotecan—peripheral nervous system neoplasm	0.000165	0.00368	CcSEcCtD
Podofilox—Haemoglobin—Isotretinoin—peripheral nervous system neoplasm	0.000165	0.00367	CcSEcCtD
Podofilox—Haemoglobin—Tretinoin—peripheral nervous system neoplasm	0.000165	0.00367	CcSEcCtD
Podofilox—Dry skin—Alitretinoin—peripheral nervous system neoplasm	0.000164	0.00367	CcSEcCtD
Podofilox—Haemorrhage—Isotretinoin—peripheral nervous system neoplasm	0.000164	0.00365	CcSEcCtD
Podofilox—Haemorrhage—Tretinoin—peripheral nervous system neoplasm	0.000164	0.00365	CcSEcCtD
Podofilox—Haemoglobin—Melphalan—peripheral nervous system neoplasm	0.000162	0.00363	CcSEcCtD
Podofilox—Haemorrhage—Melphalan—peripheral nervous system neoplasm	0.000162	0.00361	CcSEcCtD
Podofilox—Redness—Epirubicin—peripheral nervous system neoplasm	0.00016	0.00357	CcSEcCtD
Podofilox—Etoposide—ABCB1—peripheral nervous system neoplasm	0.000159	1	CrCbGaD
Podofilox—Swelling—Etoposide—peripheral nervous system neoplasm	0.000159	0.00354	CcSEcCtD
Podofilox—Blister—Epirubicin—peripheral nervous system neoplasm	0.00015	0.00335	CcSEcCtD
Podofilox—Immune system disorder—Topotecan—peripheral nervous system neoplasm	0.000149	0.00333	CcSEcCtD
Podofilox—Redness—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.00331	CcSEcCtD
Podofilox—Immune system disorder—Melphalan—peripheral nervous system neoplasm	0.000146	0.00326	CcSEcCtD
Podofilox—Erythema—Tretinoin—peripheral nervous system neoplasm	0.000143	0.00318	CcSEcCtD
Podofilox—Erythema—Isotretinoin—peripheral nervous system neoplasm	0.000143	0.00318	CcSEcCtD
Podofilox—Skin ulcer—Epirubicin—peripheral nervous system neoplasm	0.000139	0.0031	CcSEcCtD
Podofilox—Blister—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.0031	CcSEcCtD
Podofilox—Stinging—Epirubicin—peripheral nervous system neoplasm	0.000133	0.00298	CcSEcCtD
Podofilox—Haematuria—Alitretinoin—peripheral nervous system neoplasm	0.000132	0.00294	CcSEcCtD
Podofilox—Skin ulcer—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.00287	CcSEcCtD
Podofilox—Haemoglobin—Alitretinoin—peripheral nervous system neoplasm	0.000125	0.00278	CcSEcCtD
Podofilox—Haemorrhage—Alitretinoin—peripheral nervous system neoplasm	0.000124	0.00277	CcSEcCtD
Podofilox—Stinging—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.00276	CcSEcCtD
Podofilox—TOP2A—Vinorelbine—Vincristine—peripheral nervous system neoplasm	0.000123	0.101	CbGdCrCtD
Podofilox—TOP2A—Teniposide—Etoposide—peripheral nervous system neoplasm	0.000123	0.1	CbGdCrCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Topotecan—peripheral nervous system neoplasm	0.000121	0.00271	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Tretinoin—peripheral nervous system neoplasm	0.000121	0.00269	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Isotretinoin—peripheral nervous system neoplasm	0.000121	0.00269	CcSEcCtD
Podofilox—Skin discolouration—Epirubicin—peripheral nervous system neoplasm	0.00012	0.00267	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Melphalan—peripheral nervous system neoplasm	0.000119	0.00265	CcSEcCtD
Podofilox—Erythema—Dactinomycin—peripheral nervous system neoplasm	0.000116	0.0026	CcSEcCtD
Podofilox—Oedema—Isotretinoin—peripheral nervous system neoplasm	0.000116	0.0026	CcSEcCtD
Podofilox—Oedema—Tretinoin—peripheral nervous system neoplasm	0.000116	0.0026	CcSEcCtD
Podofilox—Oedema—Melphalan—peripheral nervous system neoplasm	0.000115	0.00256	CcSEcCtD
Podofilox—Ulcer—Epirubicin—peripheral nervous system neoplasm	0.000114	0.00255	CcSEcCtD
Podofilox—Skin disorder—Topotecan—peripheral nervous system neoplasm	0.000114	0.00254	CcSEcCtD
Podofilox—Skin disorder—Tretinoin—peripheral nervous system neoplasm	0.000113	0.00252	CcSEcCtD
Podofilox—Skin disorder—Isotretinoin—peripheral nervous system neoplasm	0.000113	0.00252	CcSEcCtD
Podofilox—Skin disorder—Melphalan—peripheral nervous system neoplasm	0.000112	0.00249	CcSEcCtD
Podofilox—Inflammation—Epirubicin—peripheral nervous system neoplasm	0.000111	0.00249	CcSEcCtD
Podofilox—Skin discolouration—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.00247	CcSEcCtD
Podofilox—Erythema—Alitretinoin—peripheral nervous system neoplasm	0.000108	0.00241	CcSEcCtD
Podofilox—Ulcer—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.00236	CcSEcCtD
Podofilox—Paraesthesia—Topotecan—peripheral nervous system neoplasm	0.000105	0.00235	CcSEcCtD
Podofilox—Insomnia—Tretinoin—peripheral nervous system neoplasm	0.000105	0.00235	CcSEcCtD
Podofilox—Insomnia—Isotretinoin—peripheral nervous system neoplasm	0.000105	0.00235	CcSEcCtD
Podofilox—Paraesthesia—Isotretinoin—peripheral nervous system neoplasm	0.000104	0.00233	CcSEcCtD
Podofilox—Paraesthesia—Tretinoin—peripheral nervous system neoplasm	0.000104	0.00233	CcSEcCtD
Podofilox—Skin exfoliation—Epirubicin—peripheral nervous system neoplasm	0.000103	0.0023	CcSEcCtD
Podofilox—Inflammation—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.0023	CcSEcCtD
Podofilox—Paraesthesia—Melphalan—peripheral nervous system neoplasm	0.000103	0.0023	CcSEcCtD
Podofilox—Pain—Topotecan—peripheral nervous system neoplasm	0.0001	0.00224	CcSEcCtD
Podofilox—Pain—Isotretinoin—peripheral nervous system neoplasm	9.95e-05	0.00222	CcSEcCtD
Podofilox—Pain—Tretinoin—peripheral nervous system neoplasm	9.95e-05	0.00222	CcSEcCtD
Podofilox—Pain—Melphalan—peripheral nervous system neoplasm	9.82e-05	0.00219	CcSEcCtD
Podofilox—Skin exfoliation—Doxorubicin—peripheral nervous system neoplasm	9.55e-05	0.00213	CcSEcCtD
Podofilox—Immune system disorder—Cisplatin—peripheral nervous system neoplasm	9.55e-05	0.00213	CcSEcCtD
Podofilox—Oedema—Dactinomycin—peripheral nervous system neoplasm	9.51e-05	0.00212	CcSEcCtD
Podofilox—Erythema—Cisplatin—peripheral nervous system neoplasm	9.2e-05	0.00205	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	9.13e-05	0.00204	CcSEcCtD
Podofilox—Oedema—Alitretinoin—peripheral nervous system neoplasm	8.82e-05	0.00197	CcSEcCtD
Podofilox—Immune system disorder—Etoposide—peripheral nervous system neoplasm	8.75e-05	0.00195	CcSEcCtD
Podofilox—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	8.56e-05	0.00191	CcSEcCtD
Podofilox—Oedema—Vincristine—peripheral nervous system neoplasm	8.49e-05	0.0019	CcSEcCtD
Podofilox—TOP2A—Vinblastine—Vincristine—peripheral nervous system neoplasm	8.45e-05	0.0691	CbGdCrCtD
Podofilox—Pruritus—Topotecan—peripheral nervous system neoplasm	8.3e-05	0.00185	CcSEcCtD
Podofilox—Pruritus—Tretinoin—peripheral nervous system neoplasm	8.23e-05	0.00184	CcSEcCtD
Podofilox—Pruritus—Isotretinoin—peripheral nervous system neoplasm	8.23e-05	0.00184	CcSEcCtD
Podofilox—Dermatitis bullous—Epirubicin—peripheral nervous system neoplasm	8.21e-05	0.00183	CcSEcCtD
Podofilox—Pain—Dactinomycin—peripheral nervous system neoplasm	8.13e-05	0.00181	CcSEcCtD
Podofilox—Pruritus—Melphalan—peripheral nervous system neoplasm	8.12e-05	0.00181	CcSEcCtD
Podofilox—Insomnia—Alitretinoin—peripheral nervous system neoplasm	7.97e-05	0.00178	CcSEcCtD
Podofilox—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	7.92e-05	0.00177	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	7.78e-05	0.00174	CcSEcCtD
Podofilox—Dizziness—Topotecan—peripheral nervous system neoplasm	7.75e-05	0.00173	CcSEcCtD
Podofilox—Dizziness—Tretinoin—peripheral nervous system neoplasm	7.69e-05	0.00172	CcSEcCtD
Podofilox—Dizziness—Isotretinoin—peripheral nervous system neoplasm	7.69e-05	0.00172	CcSEcCtD
Podofilox—Insomnia—Vincristine—peripheral nervous system neoplasm	7.68e-05	0.00171	CcSEcCtD
Podofilox—Paraesthesia—Vincristine—peripheral nervous system neoplasm	7.63e-05	0.0017	CcSEcCtD
Podofilox—Dermatitis bullous—Doxorubicin—peripheral nervous system neoplasm	7.6e-05	0.0017	CcSEcCtD
Podofilox—Pain—Alitretinoin—peripheral nervous system neoplasm	7.54e-05	0.00168	CcSEcCtD
Podofilox—Oedema—Cisplatin—peripheral nervous system neoplasm	7.51e-05	0.00168	CcSEcCtD
Podofilox—Vomiting—Topotecan—peripheral nervous system neoplasm	7.46e-05	0.00166	CcSEcCtD
Podofilox—Vomiting—Isotretinoin—peripheral nervous system neoplasm	7.4e-05	0.00165	CcSEcCtD
Podofilox—Vomiting—Tretinoin—peripheral nervous system neoplasm	7.4e-05	0.00165	CcSEcCtD
Podofilox—Rash—Topotecan—peripheral nervous system neoplasm	7.39e-05	0.00165	CcSEcCtD
Podofilox—Dermatitis—Topotecan—peripheral nervous system neoplasm	7.39e-05	0.00165	CcSEcCtD
Podofilox—Headache—Topotecan—peripheral nervous system neoplasm	7.35e-05	0.00164	CcSEcCtD
Podofilox—Rash—Tretinoin—peripheral nervous system neoplasm	7.33e-05	0.00164	CcSEcCtD
Podofilox—Rash—Isotretinoin—peripheral nervous system neoplasm	7.33e-05	0.00164	CcSEcCtD
Podofilox—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	7.33e-05	0.00164	CcSEcCtD
Podofilox—Dermatitis—Tretinoin—peripheral nervous system neoplasm	7.33e-05	0.00164	CcSEcCtD
Podofilox—Vomiting—Melphalan—peripheral nervous system neoplasm	7.3e-05	0.00163	CcSEcCtD
Podofilox—Skin disorder—Cisplatin—peripheral nervous system neoplasm	7.3e-05	0.00163	CcSEcCtD
Podofilox—Headache—Tretinoin—peripheral nervous system neoplasm	7.29e-05	0.00163	CcSEcCtD
Podofilox—Headache—Isotretinoin—peripheral nervous system neoplasm	7.29e-05	0.00163	CcSEcCtD
Podofilox—Pain—Vincristine—peripheral nervous system neoplasm	7.26e-05	0.00162	CcSEcCtD
Podofilox—Rash—Melphalan—peripheral nervous system neoplasm	7.24e-05	0.00162	CcSEcCtD
Podofilox—Dermatitis—Melphalan—peripheral nervous system neoplasm	7.23e-05	0.00161	CcSEcCtD
Podofilox—Dry skin—Epirubicin—peripheral nervous system neoplasm	7.19e-05	0.00161	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	7.13e-05	0.00159	CcSEcCtD
Podofilox—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	6.74e-05	0.00151	CcSEcCtD
Podofilox—Skin disorder—Etoposide—peripheral nervous system neoplasm	6.68e-05	0.00149	CcSEcCtD
Podofilox—Dry skin—Doxorubicin—peripheral nervous system neoplasm	6.66e-05	0.00149	CcSEcCtD
Podofilox—Pain—Cisplatin—peripheral nervous system neoplasm	6.42e-05	0.00143	CcSEcCtD
Podofilox—TOP2A—Daunorubicin—Epirubicin—peripheral nervous system neoplasm	6.41e-05	0.0524	CbGdCrCtD
Podofilox—TOP2A—Idarubicin—Epirubicin—peripheral nervous system neoplasm	6.41e-05	0.0524	CbGdCrCtD
Podofilox—TOP2A—Doxorubicin—Epirubicin—peripheral nervous system neoplasm	6.41e-05	0.0524	CbGdCrCtD
Podofilox—Pruritus—Alitretinoin—peripheral nervous system neoplasm	6.24e-05	0.00139	CcSEcCtD
Podofilox—Paraesthesia—Etoposide—peripheral nervous system neoplasm	6.18e-05	0.00138	CcSEcCtD
Podofilox—Vomiting—Dactinomycin—peripheral nervous system neoplasm	6.04e-05	0.00135	CcSEcCtD
Podofilox—Rash—Dactinomycin—peripheral nervous system neoplasm	5.99e-05	0.00134	CcSEcCtD
Podofilox—TOP2A—Idarubicin—Doxorubicin—peripheral nervous system neoplasm	5.93e-05	0.0485	CbGdCrCtD
Podofilox—TOP2A—Epirubicin—Doxorubicin—peripheral nervous system neoplasm	5.93e-05	0.0485	CbGdCrCtD
Podofilox—TOP2A—Daunorubicin—Doxorubicin—peripheral nervous system neoplasm	5.93e-05	0.0485	CbGdCrCtD
Podofilox—Pain—Etoposide—peripheral nervous system neoplasm	5.88e-05	0.00131	CcSEcCtD
Podofilox—Dizziness—Alitretinoin—peripheral nervous system neoplasm	5.83e-05	0.0013	CcSEcCtD
Podofilox—Haematuria—Epirubicin—peripheral nervous system neoplasm	5.77e-05	0.00129	CcSEcCtD
Podofilox—Dizziness—Vincristine—peripheral nervous system neoplasm	5.62e-05	0.00125	CcSEcCtD
Podofilox—Vomiting—Alitretinoin—peripheral nervous system neoplasm	5.6e-05	0.00125	CcSEcCtD
Podofilox—Rash—Alitretinoin—peripheral nervous system neoplasm	5.56e-05	0.00124	CcSEcCtD
Podofilox—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	5.55e-05	0.00124	CcSEcCtD
Podofilox—Headache—Alitretinoin—peripheral nervous system neoplasm	5.52e-05	0.00123	CcSEcCtD
Podofilox—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	5.46e-05	0.00122	CcSEcCtD
Podofilox—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	5.43e-05	0.00121	CcSEcCtD
Podofilox—Vomiting—Vincristine—peripheral nervous system neoplasm	5.4e-05	0.00121	CcSEcCtD
Podofilox—Rash—Vincristine—peripheral nervous system neoplasm	5.36e-05	0.0012	CcSEcCtD
Podofilox—Dermatitis—Vincristine—peripheral nervous system neoplasm	5.35e-05	0.00119	CcSEcCtD
Podofilox—Haematuria—Doxorubicin—peripheral nervous system neoplasm	5.34e-05	0.00119	CcSEcCtD
Podofilox—Headache—Vincristine—peripheral nervous system neoplasm	5.32e-05	0.00119	CcSEcCtD
Podofilox—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	5.05e-05	0.00113	CcSEcCtD
Podofilox—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	5.02e-05	0.00112	CcSEcCtD
Podofilox—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	4.9e-05	0.00109	CcSEcCtD
Podofilox—Pruritus—Etoposide—peripheral nervous system neoplasm	4.87e-05	0.00109	CcSEcCtD
Podofilox—Vomiting—Cisplatin—peripheral nervous system neoplasm	4.78e-05	0.00107	CcSEcCtD
Podofilox—Rash—Cisplatin—peripheral nervous system neoplasm	4.74e-05	0.00106	CcSEcCtD
Podofilox—Dermatitis—Cisplatin—peripheral nervous system neoplasm	4.73e-05	0.00106	CcSEcCtD
Podofilox—Erythema—Epirubicin—peripheral nervous system neoplasm	4.73e-05	0.00105	CcSEcCtD
Podofilox—Dizziness—Etoposide—peripheral nervous system neoplasm	4.55e-05	0.00102	CcSEcCtD
Podofilox—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	4.54e-05	0.00101	CcSEcCtD
Podofilox—Vomiting—Etoposide—peripheral nervous system neoplasm	4.38e-05	0.000976	CcSEcCtD
Podofilox—Erythema—Doxorubicin—peripheral nervous system neoplasm	4.37e-05	0.000976	CcSEcCtD
Podofilox—Rash—Etoposide—peripheral nervous system neoplasm	4.34e-05	0.000968	CcSEcCtD
Podofilox—Dermatitis—Etoposide—peripheral nervous system neoplasm	4.33e-05	0.000967	CcSEcCtD
Podofilox—Headache—Etoposide—peripheral nervous system neoplasm	4.31e-05	0.000962	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	4e-05	0.000892	CcSEcCtD
Podofilox—Oedema—Epirubicin—peripheral nervous system neoplasm	3.86e-05	0.000861	CcSEcCtD
Podofilox—Skin disorder—Epirubicin—peripheral nervous system neoplasm	3.75e-05	0.000836	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	3.7e-05	0.000825	CcSEcCtD
Podofilox—TOP2A—Gastric Cancer Network 1—AURKA—peripheral nervous system neoplasm	3.62e-05	0.0477	CbGpPWpGaD
Podofilox—Oedema—Doxorubicin—peripheral nervous system neoplasm	3.57e-05	0.000797	CcSEcCtD
Podofilox—Insomnia—Epirubicin—peripheral nervous system neoplasm	3.49e-05	0.000779	CcSEcCtD
Podofilox—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	3.47e-05	0.000774	CcSEcCtD
Podofilox—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	3.46e-05	0.000773	CcSEcCtD
Podofilox—TOP2A—Retinoblastoma (RB) in Cancer—BARD1—peripheral nervous system neoplasm	3.37e-05	0.0444	CbGpPWpGaD
Podofilox—Pain—Epirubicin—peripheral nervous system neoplasm	3.3e-05	0.000736	CcSEcCtD
Podofilox—Insomnia—Doxorubicin—peripheral nervous system neoplasm	3.23e-05	0.00072	CcSEcCtD
Podofilox—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	3.2e-05	0.000715	CcSEcCtD
Podofilox—Pain—Doxorubicin—peripheral nervous system neoplasm	3.05e-05	0.000681	CcSEcCtD
Podofilox—TUBA4A—Regulation of PLK1 Activity at G2/M Transition—AURKA—peripheral nervous system neoplasm	2.73e-05	0.036	CbGpPWpGaD
Podofilox—Pruritus—Epirubicin—peripheral nervous system neoplasm	2.73e-05	0.000609	CcSEcCtD
Podofilox—Dizziness—Epirubicin—peripheral nervous system neoplasm	2.55e-05	0.000569	CcSEcCtD
Podofilox—Pruritus—Doxorubicin—peripheral nervous system neoplasm	2.53e-05	0.000564	CcSEcCtD
Podofilox—Vomiting—Epirubicin—peripheral nervous system neoplasm	2.45e-05	0.000547	CcSEcCtD
Podofilox—Rash—Epirubicin—peripheral nervous system neoplasm	2.43e-05	0.000543	CcSEcCtD
Podofilox—Dermatitis—Epirubicin—peripheral nervous system neoplasm	2.43e-05	0.000542	CcSEcCtD
Podofilox—Headache—Epirubicin—peripheral nervous system neoplasm	2.42e-05	0.000539	CcSEcCtD
Podofilox—Dizziness—Doxorubicin—peripheral nervous system neoplasm	2.36e-05	0.000527	CcSEcCtD
Podofilox—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—GNAS—peripheral nervous system neoplasm	2.33e-05	0.0307	CbGpPWpGaD
Podofilox—TUBB—Regulation of PLK1 Activity at G2/M Transition—AURKA—peripheral nervous system neoplasm	2.32e-05	0.0306	CbGpPWpGaD
Podofilox—TUBA4A—Platelet degranulation—KNG1—peripheral nervous system neoplasm	2.31e-05	0.0305	CbGpPWpGaD
Podofilox—Vomiting—Doxorubicin—peripheral nervous system neoplasm	2.27e-05	0.000506	CcSEcCtD
Podofilox—Rash—Doxorubicin—peripheral nervous system neoplasm	2.25e-05	0.000502	CcSEcCtD
Podofilox—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	2.25e-05	0.000502	CcSEcCtD
Podofilox—Headache—Doxorubicin—peripheral nervous system neoplasm	2.24e-05	0.000499	CcSEcCtD
Podofilox—TUBA4A—Response to elevated platelet cytosolic Ca2+—KNG1—peripheral nervous system neoplasm	2.2e-05	0.029	CbGpPWpGaD
Podofilox—NR3C1—FOXA2 and FOXA3 transcription factor networks—NF1—peripheral nervous system neoplasm	2.2e-05	0.029	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—NTS—peripheral nervous system neoplasm	2.09e-05	0.0275	CbGpPWpGaD
Podofilox—TUBA4A—G2/M Transition—AURKA—peripheral nervous system neoplasm	2.05e-05	0.027	CbGpPWpGaD
Podofilox—TUBA4A—Mitotic G2-G2/M phases—AURKA—peripheral nervous system neoplasm	2.02e-05	0.0267	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	2.01e-05	0.0265	CbGpPWpGaD
Podofilox—TUBA4A—Platelet degranulation—HGF—peripheral nervous system neoplasm	1.93e-05	0.0254	CbGpPWpGaD
Podofilox—TUBA4A—Response to elevated platelet cytosolic Ca2+—HGF—peripheral nervous system neoplasm	1.84e-05	0.0242	CbGpPWpGaD
Podofilox—TUBB—G2/M Transition—AURKA—peripheral nervous system neoplasm	1.74e-05	0.023	CbGpPWpGaD
Podofilox—TUBB—Mitotic G2-G2/M phases—AURKA—peripheral nervous system neoplasm	1.72e-05	0.0227	CbGpPWpGaD
Podofilox—CYP3A4—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	1.51e-05	0.0199	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	1.46e-05	0.0193	CbGpPWpGaD
Podofilox—CYP3A4—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	1.28e-05	0.0169	CbGpPWpGaD
Podofilox—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—peripheral nervous system neoplasm	1.06e-05	0.0139	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	1.03e-05	0.0135	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—TH—peripheral nervous system neoplasm	1e-05	0.0132	CbGpPWpGaD
Podofilox—TOP2A—Gastric Cancer Network 2—MYC—peripheral nervous system neoplasm	9.99e-06	0.0132	CbGpPWpGaD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—IFNB1—peripheral nervous system neoplasm	9.01e-06	0.0119	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	8.55e-06	0.0113	CbGpPWpGaD
Podofilox—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	8.29e-06	0.0109	CbGpPWpGaD
Podofilox—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	8.27e-06	0.0109	CbGpPWpGaD
Podofilox—TOP2A—Gastric Cancer Network 2—TP53—peripheral nervous system neoplasm	8.21e-06	0.0108	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	7.17e-06	0.00945	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—TH—peripheral nervous system neoplasm	7.05e-06	0.00929	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	6.53e-06	0.00861	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—AURKA—peripheral nervous system neoplasm	6.52e-06	0.0086	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	6.27e-06	0.00827	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	5.98e-06	0.00789	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	5.88e-06	0.00776	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—AURKA—peripheral nervous system neoplasm	5.83e-06	0.00769	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	5.78e-06	0.00761	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—IFNB1—peripheral nervous system neoplasm	5.71e-06	0.00752	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—AURKA—peripheral nervous system neoplasm	5.55e-06	0.00731	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	5.29e-06	0.00698	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—KNG1—peripheral nervous system neoplasm	5.29e-06	0.00697	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—CHEK2—peripheral nervous system neoplasm	5.22e-06	0.00688	CbGpPWpGaD
Podofilox—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	4.98e-06	0.00657	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—AURKA—peripheral nervous system neoplasm	4.96e-06	0.00654	CbGpPWpGaD
Podofilox—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	4.75e-06	0.00626	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—BCHE—peripheral nervous system neoplasm	4.74e-06	0.00625	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—CDKN2A—peripheral nervous system neoplasm	4.71e-06	0.00621	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—GNAS—peripheral nervous system neoplasm	4.62e-06	0.0061	CbGpPWpGaD
Podofilox—TOP2A—Mitotic G1-G1/S phases—CDKN2A—peripheral nervous system neoplasm	4.54e-06	0.00599	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—CHEK2—peripheral nervous system neoplasm	4.44e-06	0.00585	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—HGF—peripheral nervous system neoplasm	4.4e-06	0.00581	CbGpPWpGaD
Podofilox—TOP2A—Retinoblastoma (RB) in Cancer—MYC—peripheral nervous system neoplasm	4.38e-06	0.00577	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	4.31e-06	0.00568	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—BIRC5—peripheral nervous system neoplasm	4.23e-06	0.00558	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—AURKA—peripheral nervous system neoplasm	3.88e-06	0.00512	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—BIRC5—peripheral nervous system neoplasm	3.78e-06	0.00499	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—BIRC5—peripheral nervous system neoplasm	3.6e-06	0.00474	CbGpPWpGaD
Podofilox—TOP2A—Retinoblastoma (RB) in Cancer—TP53—peripheral nervous system neoplasm	3.59e-06	0.00474	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—AURKA—peripheral nervous system neoplasm	3.47e-06	0.00457	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	3.29e-06	0.00434	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—BIRC5—peripheral nervous system neoplasm	3.22e-06	0.00424	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—PTPN11—peripheral nervous system neoplasm	3.21e-06	0.00424	CbGpPWpGaD
Podofilox—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—peripheral nervous system neoplasm	3.21e-06	0.00423	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—MYC—peripheral nervous system neoplasm	3.19e-06	0.00421	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CHEK2—peripheral nervous system neoplasm	3.1e-06	0.00409	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—EED—peripheral nervous system neoplasm	3.09e-06	0.00408	CbGpPWpGaD
Podofilox—TOP2A—Mitotic G1-G1/S phases—MYC—peripheral nervous system neoplasm	3.08e-06	0.00406	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	2.99e-06	0.00394	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	2.97e-06	0.00392	CbGpPWpGaD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—peripheral nervous system neoplasm	2.84e-06	0.00375	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—CDKN2A—peripheral nervous system neoplasm	2.8e-06	0.0037	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—TP53—peripheral nervous system neoplasm	2.62e-06	0.00346	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—BIRC5—peripheral nervous system neoplasm	2.52e-06	0.00332	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—CDKN2A—peripheral nervous system neoplasm	2.51e-06	0.0033	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—SUZ12—peripheral nervous system neoplasm	2.47e-06	0.00326	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	2.42e-06	0.00319	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—CDKN2A—peripheral nervous system neoplasm	2.38e-06	0.00314	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	2.33e-06	0.00308	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—TP53—peripheral nervous system neoplasm	2.31e-06	0.00305	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—BIRC5—peripheral nervous system neoplasm	2.25e-06	0.00296	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	2.15e-06	0.00284	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—CDKN2A—peripheral nervous system neoplasm	2.13e-06	0.00281	CbGpPWpGaD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—peripheral nervous system neoplasm	1.97e-06	0.0026	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.96e-06	0.00258	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—AKT1—peripheral nervous system neoplasm	1.95e-06	0.00257	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—NRAS—peripheral nervous system neoplasm	1.93e-06	0.00255	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	1.92e-06	0.00253	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	1.9e-06	0.0025	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	1.84e-06	0.00243	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—MYC—peripheral nervous system neoplasm	1.7e-06	0.00224	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—CDKN2A—peripheral nervous system neoplasm	1.67e-06	0.0022	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.62e-06	0.00213	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	1.62e-06	0.00213	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CDKN2A—peripheral nervous system neoplasm	1.49e-06	0.00196	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—TP53—peripheral nervous system neoplasm	1.48e-06	0.00195	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—MYC—peripheral nervous system neoplasm	1.44e-06	0.0019	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—HRAS—peripheral nervous system neoplasm	1.41e-06	0.00186	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—TP53—peripheral nervous system neoplasm	1.39e-06	0.00184	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.32e-06	0.00175	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—AKT1—peripheral nervous system neoplasm	1.25e-06	0.00165	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—TP53—peripheral nervous system neoplasm	1.19e-06	0.00156	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.18e-06	0.00155	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	1.13e-06	0.00149	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.1e-06	0.00145	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—MYC—peripheral nervous system neoplasm	1.01e-06	0.00133	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GNS—peripheral nervous system neoplasm	9.57e-07	0.00126	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—NME1—peripheral nervous system neoplasm	9.18e-07	0.00121	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—COX2—peripheral nervous system neoplasm	8.83e-07	0.00116	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—TP53—peripheral nervous system neoplasm	8.29e-07	0.00109	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	7.96e-07	0.00105	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	7.1e-07	0.000937	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ENO2—peripheral nervous system neoplasm	5.8e-07	0.000765	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	5.76e-07	0.000759	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	5.52e-07	0.000728	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	5.31e-07	0.0007	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	4.9e-07	0.000646	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.67e-07	0.000616	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	4.61e-07	0.000607	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	3.76e-07	0.000496	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	3.69e-07	0.000487	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	3.49e-07	0.00046	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—MYC—peripheral nervous system neoplasm	3.42e-07	0.000451	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	2.95e-07	0.000388	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.81e-07	0.000371	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	2.77e-07	0.000365	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—AKT1—peripheral nervous system neoplasm	2.37e-07	0.000313	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	2.26e-07	0.000298	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	2.22e-07	0.000293	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	1.02e-07	0.000134	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	6.1e-08	8.05e-05	CbGpPWpGaD
